Company intelligence / Profile preview

Remer Consult

Ownership: Private
Development stage: Other

Overview

Remer is an enterprise dedicated to the fields of life science and biotechnology. The company provides high-quality products and technical services, leveraging a professional team with many years of experience. Its business philosophy emphasizes customer-first service and integrity. There is no public information indicating that Remer develops its own therapeutic pipeline or clinical programs.

Industry: Consulting

Beyond the preview

Go deeper on Remer Consult.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remer Consult.

Explore the full profile